ArticleAmerican journal of translational research2018

MiR-106a* inhibits oral squamous cell carcinoma progression by directly targeting MeCP2 and suppressing the Wnt/β-Catenin signaling pathway.

Nan Zhang et al.PubMed ↗Full text ↗

No numbers read from the abstract.